Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06018337
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2023-08-25
Brief Title:
A Study of DB-1303BNT323 vs Investigators Choice Chemotherapy in HER2-Low Hormone Receptor Positive Metastatic Breast Cancer DYNASTY-Breast02
Sponsor:
DualityBio Inc
Organization:
DualityBio Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-25
First Submit QC Date:
August 25 2023
Study First Post Date:
2023-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL